Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - IDEX CORP /DE/ | iex-20161018xex992.htm |
| 8-K - 8-K - IDEX CORP /DE/ | iex-20161018x8k.htm |
IDEX Proprietary & Confidential
Third Quarter Earnings
October 18, 2016
IDEX Proprietary & Confidential
Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries
• IDEX’s Outlook
• Q3 2016 Financial Performance
• Q3 2016 Segment Performance
• Fluid & Metering
• Health & Science
• Fire & Safety / Diversified Products
• 2016 Guidance Summary
• Q&A
1
AGENDA
IDEX Proprietary & Confidential
Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries
• Dial toll–free: 877.660.6853
• International: 201.612.7415
• Conference ID: #13620008
• Log on to: www.idexcorp.com
2
Replay Information
IDEX Proprietary & Confidential
Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries
Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures
This presentation and discussion will include forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, capital expenditures,
acquisitions, cost reductions, cash flow, revenues, earnings, market conditions, global economies and operating
improvements, and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,”
“forecasts,” “should,” “could,” “will,” “management believes,” “the company believes,” “the company intends,” and
similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual
results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include,
but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars;
levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures
and other competitive factors, and levels of capital spending in certain industries – all of which could have a material
impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains;
its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship
of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic
conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has
on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such
as litigation and environmental matters. Additional factors that could cause actual results to differ materially from those
reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors”
section included in the company’s most recent annual report on Form 10-K filed with the SEC and the other risks
discussed in the company’s filings with the SEC. The forward-looking statements included in this presentation and
discussion are only made as of today’s date, and management undertakes no obligation to publicly update them to
reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely
unduly on forward-looking statements when evaluating the information in this presentation and discussion.
This presentation contains non-GAAP financial information. Reconciliations of non-GAAP measures are included either
in this presentation or our earnings release for the three-month period ending September 30, 2016, which is available on
our website.
3
IDEX Proprietary & Confidential
Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries
$100
$105
$110
$115
Q3
$105
$114
2015 2016
16.0%
18.0%
20.0%
22.0%
Q3
21.5% 20.9%
2015 2016
$0.86
$0.88
$0.90
$0.92
$0.94
Q3
$0.89
$0.92
2015 2016
$0
$200
$400
$600
Q3
$504 $530
2015 2016
4
IDEX Q3 Financial Performance
Sales Adjusted EPS*
Adjusted Operating Margin* Free Cash Flow
60 bps Decrease
3% Increase
9% Increase
Sales were up 5 percent with Free Cash Flow of $114 million or 163 percent of net income
(Dollars in millions, excl. EPS)
Organic: 2% Decrease
* Q3’15 adjusted for restructuring expenses ($4.7M) and the gain on divestiture ($18.1M), while Q3’16 adjusted for the net loss on divestitures ($2.1M).
IDEX Proprietary & Confidential
Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries
5
Fluid & Metering
Orders Sales
Q3 Sales Mix: Organic 0%
Divestiture (1%)
Fx (1%)
Reported Sales (2%)
Q3 Summary:
Water market remains solid with positive outlook for remainder of the
year
Industrial market remains stable, but still down year-over-year
Energy mobile and LPG markets are tough while aviation market
remains solid
Ag remains soft, but it feels like we’ve hit the bottom
Adjusted Operating Margin*
Industrial market continues to be a challenge to growth in FMT
$0
$100
$200
$300
Q3
$210 $204
2015 2016
21.0%
23.0%
25.0%
27.0%
Q3
23.3%
26.7%
2015 2016
$0
$100
$200
$300
Q3
$212 $208
2015 16
340 bps Increase Organic: 1% Decrease Organic: Flat
* Q3’15 adjusted for restructuring expenses ($2.5M).
(Dollars in millions)
IDEX Proprietary & Confidential
Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries
6
Health & Science
Orders Sales Adjusted Operating Margin*
Q3 Sales Mix: Organic (1%)
Acquisition/Divestiture 2%
Fx (2%)
Reported Sales
(1%)
Q3 Summary:
Scientific Fluidics remains strong and continues to exceed expectations
Pharma market remains strong, especially in Asia
Industrial distribution remains a major challenge
Sealing continues to be driven by strength in semiconductor market while
the oil & gas market is weak
Solid 4 percent organic order growth – SFC Koenig acquired on September 1st
$0
$50
$100
$150
$200
Q3
$177 $186
2015 2016
$0
$50
$100
$150
$200
Q3
$185 $184
2015 2016
19.0%
20.0%
21.0%
22.0%
Q3
21.7%
20.3%
2015 2016
Organic: 4% Increase Organic: 1% Decrease 140 bps Decrease
* Q3’15 adjusted for restructuring expenses ($1.8M).
(Dollars in millions)
IDEX Proprietary & Confidential
Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries
7
Fire & Safety / Diversified Products
Orders Sales Adjusted Operating Margin*
Q3 Summary:
Integration of Akron Brass and AWG, although in the early stages, is
progressing extremely well
Dispensing seeing strength across the globe with our X-Smart product in
strong demand
Band-It’s transportation market continues to show solid growth
Organic order increase of 4 percent
Q3 Sales Mix: Organic (6%)
Acquisitions 38%
Fx (2%)
Reported Sales 30%
$0
$50
$100
$150
Q3
$99
$140
2015 2016
Organic: 4% Increase
$0
$50
$100
$150
Q3
$107
$139
2015 2016
15.0%
20.0%
25.0%
30.0%
35.0%
Q3
30.7%
23.2%
2015 2016
Organic: 6% Decrease 750 bps Decrease
* Q3’15 adjusted for restructuring expenses ($0.3M).
(Dollars in millions)
IDEX Proprietary & Confidential
Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries
Q4 2016
– Adjusted EPS estimate range: $0.92 – $0.94
– Organic revenue growth: 1%
– Adjusted operating margin: ~ 19.5% (including $5 million of inventory fair value step-up charge for SFC)
– Tax rate: ~ 27%
– Fx impact: ~1.0% topline headwind, based on September 30, 2016 Fx rates
FY 2016
– Adjusted EPS estimate range: $3.72 – $3.74
– Organic revenue growth: ~ -1%
– Adjusted operating margin: 20.5%
– Fx impact: ~1.0% topline headwind, based on September 30, 2016 Fx rates
– Tax rate: ~ 27.5%
– Other modeling items
• Cap Ex: ~ $40M
• Free Cash Flow will be ~120% of net income
• Share repurchases: ~ net 1% reduction
• EPS estimate excludes all future acquisitions/divestitures and associated costs, pension settlement charges and restructuring
costs
8
Outlook: 2016 Guidance Summary